TOP2A and neoplasm: Enrichment analysis and preliminary in vitro and in vivo experiments confirmed that TOP2A, mediating the Hippo-YAP signal pathway, could promote cancer cell growth, bone-specific metastatic potential and tumor-induced osteolysis in LIHC.